AstraZeneca's £4.4m package for former boss David Brennan

 

Tuesday 17 July 2012 13:21
Comments

AstraZeneca paid its former chief executive David Brennan up to £4.4m on top of his pension pot totalling £14m, it emerged yesterday.

However, Mr Brennan, who quit after growing pressure on him from shareholders, waived his bonus for the first five months of 2012 following his sudden departure after poor sales and setbacks with its pipeline of new drugs.

The company released figures in its annual report showing Mr Brennan got a lump sum of £914,122 as part of his notice period plus a share award of £1.5m for 2010 and a potential £2m more depending on previous share awards' performance.

The report said his £14m pension pot, which was accrued over his 36 years at the company, would pay him around £970,000 a year.

Mr Brennan has said that the decision on his departure in April had been made "totally" by himself.

However, shareholders had pushed for his departure in what was a key moment of the so-called "shareholder spring".

Register for free to continue reading

Registration is a free and easy way to support our truly independent journalism

By registering, you will also enjoy limited access to Premium articles, exclusive newsletters, commenting, and virtual events with our leading journalists

Please enter a valid email
Please enter a valid email
Must be at least 6 characters, include an upper and lower case character and a number
Must be at least 6 characters, include an upper and lower case character and a number
Must be at least 6 characters, include an upper and lower case character and a number
Please enter your first name
Special characters aren’t allowed
Please enter a name between 1 and 40 characters
Please enter your last name
Special characters aren’t allowed
Please enter a name between 1 and 40 characters
You must be over 18 years old to register
You must be over 18 years old to register
Opt-out-policy
You can opt-out at any time by signing in to your account to manage your preferences. Each email has a link to unsubscribe.

By clicking ‘Create my account’ you confirm that your data has been entered correctly and you have read and agree to our Terms of use, Cookie policy and Privacy notice.

This site is protected by reCAPTCHA and the Google Privacy policy and Terms of service apply.

Already have an account? sign in

By clicking ‘Register’ you confirm that your data has been entered correctly and you have read and agree to our Terms of use, Cookie policy and Privacy notice.

This site is protected by reCAPTCHA and the Google Privacy policy and Terms of service apply.

Register for free to continue reading

Registration is a free and easy way to support our truly independent journalism

By registering, you will also enjoy limited access to Premium articles, exclusive newsletters, commenting, and virtual events with our leading journalists

Already have an account? sign in

By clicking ‘Register’ you confirm that your data has been entered correctly and you have read and agree to our Terms of use, Cookie policy and Privacy notice.

This site is protected by reCAPTCHA and the Google Privacy policy and Terms of service apply.

Join our new commenting forum

Join thought-provoking conversations, follow other Independent readers and see their replies

Comments

Thank you for registering

Please refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged in